137 related articles for article (PubMed ID: 15379950)
1. Interstitial pneumonitis related to flutamide monotherapy for prostate cancer.
Nomura M; Sato H; Fujimoto N; Matsumoto T
Int J Urol; 2004 Sep; 11(9):798-800. PubMed ID: 15379950
[TBL] [Abstract][Full Text] [Related]
2. Interstitial pneumonitis related to leuprorelin acetate and flutamide.
Azuma T; Kurimoto S; Mikami K; Oshi M
J Urol; 1999 Jan; 161(1):221. PubMed ID: 10037405
[No Abstract] [Full Text] [Related]
3. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
Patel H; Rhee E; Zimmern PE
J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
[TBL] [Abstract][Full Text] [Related]
4. [Fulminant hepatitis caused by flutamide].
Andréjak M; Nguyen-Khac E; Decocq G; Capron JP
Gastroenterol Clin Biol; 1996 Feb; 20(1):121-2. PubMed ID: 8734324
[No Abstract] [Full Text] [Related]
5. Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy.
Karamanakos P; Mitsiades CS; Lembessis P; Kontos M; Trafalis D; Koutsilieris M
Anticancer Res; 2004; 24(2C):1077-81. PubMed ID: 15154626
[TBL] [Abstract][Full Text] [Related]
6. Successful recovery from interstitial pneumonitis, induced by bicalutamide and leuprorelin acetate given as treatment for prostate cancer.
Shioi K; Sakai N; Yoshida M; Nakamura M
Hinyokika Kiyo; 2005 Mar; 51(3):211-4. PubMed ID: 15852680
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant hormone therapy and radical radiotherapy for localized prostate cancer: poorer biochemical outcome using flutamide alone.
Wilson KS; Ludgate CM; Wilson AG; Alexander AS
Can J Urol; 2000 Oct; 7(5):1099-103. PubMed ID: 11114872
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic lung disease induced by bicalutamide: a case report and review of the medical literature.
Wong PW; Macris N; DiFabrizio L; Seriff NS
Chest; 1998 Feb; 113(2):548-50. PubMed ID: 9498983
[TBL] [Abstract][Full Text] [Related]
9. Is prednisolone as good as flutamide in hormone refractory metastatic carcinoma of the prostate?
Datta SN; Thomas K; Matthews PN
J Urol; 1997 Jul; 158(1):175-7. PubMed ID: 9186348
[TBL] [Abstract][Full Text] [Related]
10. [Antiandrogen in prostate cancer].
Maeda O; Usami M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
[No Abstract] [Full Text] [Related]
11. Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer.
Wieder JA; Soloway MS
J Urol; 1998 Jun; 159(6):2099. PubMed ID: 9598539
[No Abstract] [Full Text] [Related]
12. [Changes in liver function induced by flutamide in patients with prostate cancer (studies in patients treated with total androgen blockage)].
Ikemoto I; Ohishi Y; Yamazaki H; Wada T; Aizawa Y
Nihon Hinyokika Gakkai Zasshi; 2000 Jun; 91(6):556-61. PubMed ID: 10897581
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer.
Sharma JJ; Razvillas B; Stephens CD; Hilsenbeck SG; Sharma A; Rothenberg ML
Invest New Drugs; 1997; 15(4):361-4. PubMed ID: 9547680
[TBL] [Abstract][Full Text] [Related]
14. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial.
Alberts SR; Novotny PJ; Sloan JA; Danella J; Bostwick DG; Sebo TJ; Blute ML; Fitch TR; Levitt R; Lieberman R; Loprinzi CL
Am J Ther; 2006; 13(4):291-7. PubMed ID: 16858161
[TBL] [Abstract][Full Text] [Related]
15. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
[TBL] [Abstract][Full Text] [Related]
16. Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal.
Herrada J; Dieringer P; Logothetis CJ
J Urol; 1996 Feb; 155(2):620-3. PubMed ID: 8558675
[TBL] [Abstract][Full Text] [Related]
17. [Toxic hepatitis and liver failure under therapy with flutamide].
Lübbert C; Wiese M; Haupt R; Ruf BR
Internist (Berl); 2004 Mar; 45(3):333-40. PubMed ID: 14997310
[TBL] [Abstract][Full Text] [Related]
18. Microscopic polyangiitis complicated by the development of prostate cancer and flutamide-induced hepatitis.
Papaioannides D; Korantzopoulos P; Bouropoulos C; Latsi P; Fotinou M; Orphanidou D
Int Urol Nephrol; 2005; 37(3):515-20. PubMed ID: 16307333
[TBL] [Abstract][Full Text] [Related]
19. Flutamide-induced acute hepatitis in advanced prostate cancer patients.
Kraus I; Vitezic D; Oguic R
Int J Clin Pharmacol Ther; 2001 Sep; 39(9):395-9. PubMed ID: 11563686
[TBL] [Abstract][Full Text] [Related]
20. Re: Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.
Caubet JF
J Natl Cancer Inst; 1999 Feb; 91(4):381-2. PubMed ID: 10050874
[No Abstract] [Full Text] [Related]
[Next] [New Search]
